Successful treatment of extramedullary gastric plasmacytoma with the combination of bortezomib and dexamethasone: First reported case

Leukemia Research

Volumn 32, Issue 2, 2008, Pages 339-341

  Katodritou, Eirini ^a   Kartsios, Charalambos ^a   Gastari, Vassiliki ^a   Verrou, Evgenia ^a   Mihou, Dimitra ^a   Banti, Anastasia ^a   Lazaraki, Georgia ^a   Lazaridou, Anna ^a   Kaloutsi, Vassiliki ^a   Zervas, Konstantinos ^a  

^a THEAGENIO CANCER HOSPITAL   (Greece)

Author keywords

Bortezomib; Dexamethasone; Extramedullary gastric plasmacytoma

Indexed keywords

BORTEZOMIB; DEXAMETHASONE;

AGED; ARTICLE; BLOOD CELL COUNT; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; DRUG TOLERABILITY; GASTRIC PLASMACYTOMA; GASTROINTESTINAL HEMORRHAGE; GASTROSCOPY; HISTOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; IRON DEFICIENCY ANEMIA; MALE; MULTIPLE CYCLE TREATMENT; PLASMACYTOMA; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH TUMOR; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BORONIC ACIDS; DEXAMETHASONE; HUMANS; MALE; MIDDLE AGED; PLASMACYTOMA; PYRAZINES; STOMACH NEOPLASMS;

EID: 38949192183     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.04.016     Document Type: Article

References (8)

1. Dimopoulos M.A., Kiamouris C., and Moulopoulos L.A. Solitary plasmacytomas of bone and extramedullary plasmacytoma. Hematol Oncol Clin N Am 13 (1999) 1249-1257
2. Grogen T.M., and Spier C.M. The B cell immunoproliferative disorders, including multiple myeloma and amyloidosis. In: Knowles D.M. (Ed). Neoplastic hematopathology (1992), Williams and Wilkins, Baltimore, MD 1235-1265
3. Galieni P., Cavo M., Pulsoni A., Avissati G., Bigazzi C., Neri S., et al. Clinical outcome of extramedullary plasmacytoma. Haematologica 85 (2000) 47-51
4. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extamedullary plasmacytoma. Br J Haematol 2004;124:717-26.
5. The International Myeloma working Group: Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003;121:749-57.
6. Laura R., Cibeira M.T., Uriburu C., Yantorno S., Salamero O., Blade J., et al. Bortezomib: an effective agent in extramedullary disease in multiple myeloma. Eur J Haematol 76 (2006) 405-408
7. Dolin S., and Dewer J. Extramedullary plasmacytoma. Am J Pathol 32 (1955) 83-103
8. Coia L.R., Myerson R.J., and Tepper J.E. Late effects of radiation therapy on the gastrointestinal tract. Int J Radiat Oncol Biol Phys 31 (1995) 1213-1236